Catalyst Funds Management’s Inozyme Pharma INZY Stock Holding History

Catalyst Funds Management’s Portfolio INZY Stock Details INZY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-15,000	Closed	-$60K	–	577
2025 Q2	$60K	Buy	+15,000	New	+$37.1K	0.02%	358

Catalyst Funds Management's INZY Position: Q3 2025 in Review

Catalyst Funds Management sold out of Inozyme Pharma (INZY) in Q3 2025, closing a stake of 15,000 shares — an estimated $60K sold.

Catalyst Funds Management first reported a position in INZY in Q2 2025 and held it in 1 quarter. The position peaked at $60K in Q2 2025. 0 funds tracked by Wall St. Rank hold INZY as of Q3 2025.

Catalyst Funds Management reported no remaining Inozyme Pharma position as of Q3 2025 after selling out during the quarter.
Catalyst Funds Management sold 15,000 Inozyme Pharma shares in Q3 2025, an estimated $60K.
Catalyst Funds Management first reported a position in Inozyme Pharma in Q2 2025 and held it in 1 quarter.
Catalyst Funds Management's Inozyme Pharma position peaked at $60K in Q2 2025.
0 funds tracked by Wall St. Rank held Inozyme Pharma as of Q3 2025.

Based on Catalyst Funds Management's 13F filing for Q3 2025, filed 12 Nov 2025.